van Vollenhoven RF - Search Results

1

An open study of dehydroepiandrosterone in systemic lupus erythematosus.

van Vollenhoven RF, Engleman EG, McGuire JL. van Vollenhoven RF, et al. Arthritis Rheum. 1994 Sep;37(9):1305-10. doi: 10.1002/art.1780370906. Arthritis Rheum. 1994. PMID: 7945493 Clinical Trial.

2

Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND.

van Vollenhoven RF, Hall S, Wells AF, Meerwein S, Song Y, Tanjinatus O, Fleischmann R. van Vollenhoven RF, et al. RMD Open. 2024 Jul 24;10(3):e004037. doi: 10.1136/rmdopen-2023-004037. RMD Open. 2024. PMID: 39053948 Free PMC article. Clinical Trial.

3

Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?

Van Vollenhoven RF, McGuire JL. Van Vollenhoven RF, et al. Cleve Clin J Med. 1994 Jul-Aug;61(4):276-84. doi: 10.3949/ccjm.61.4.276. Cleve Clin J Med. 1994. PMID: 7923746 Free article. Review.

4

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.

van Vollenhoven RF, Engleman EG, McGuire JL. van Vollenhoven RF, et al. Arthritis Rheum. 1995 Dec;38(12):1826-31. doi: 10.1002/art.1780381216. Arthritis Rheum. 1995. PMID: 8849355 Clinical Trial.

5

Systemic lupus erythematosus and pregnancy.

Druzin ML, Van Vollenhoven RF. Druzin ML, et al. Among authors: van vollenhoven rf. Ann Med Interne (Paris). 1996;147(4):265-73. Ann Med Interne (Paris). 1996. PMID: 8952746 Review.

6

Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.

Van Vollenhoven RF, McGuire JL. Van Vollenhoven RF, et al. Ann Med Interne (Paris). 1996;147(4):290-6. Ann Med Interne (Paris). 1996. PMID: 8952750 Review.

7

Skeletal status of men with early and late ankylosing spondylitis.

Lee YS, Schlotzhauer T, Ott SM, van Vollenhoven RF, Hunter J, Shapiro J, Marcus R, McGuire JL. Lee YS, et al. Among authors: van vollenhoven rf. Am J Med. 1997 Sep;103(3):233-41. doi: 10.1016/s0002-9343(97)00143-5. Am J Med. 1997. PMID: 9316556 Free article.

8

Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. van Vollenhoven RF, et al. J Rheumatol. 1998 Feb;25(2):285-9. J Rheumatol. 1998. PMID: 9489820 Clinical Trial.

9

Socioeconomic status and health in women with systemic lupus erythematosus.

Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Lotstein DS, et al. J Rheumatol. 1998 Sep;25(9):1720-9. J Rheumatol. 1998. PMID: 9733452

10

Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.

Barry NN, McGuire JL, van Vollenhoven RF. Barry NN, et al. Among authors: van vollenhoven rf. J Rheumatol. 1998 Dec;25(12):2352-6. J Rheumatol. 1998. PMID: 9858429 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

493 results

Search Page

Filters